Benitec Biopharma Inc.
BNTC | NASDAQ
$10.88
-$0.14 (-1.27%)
At close: Sep 21, 2026, 4:00 PM ET
$10.88
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:10 PM ET
Fiscal Year Period Ending | FY 2026 Jun 29, 2026 | FY 2025 Jun 29, 2025 | FY 2024 Jun 29, 2024 | FY 2023 Jun 29, 2023 | FY 2022 Jun 29, 2022 | FY 2021 Jun 29, 2021 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | 75K | 73K | 59K |
Cost of Revenue | 481K | 396K | 343K | n/a | 9K | 123K |
Gross Profit | -481K | -396K | -343K | 75K | 64K | -64K |
Operating Income | -51.19M | -41.77M | -22.49M | -19.08M | -17.85M | -13.6M |
Interest Income | 5.57M | n/a | 904K | n/a | n/a | n/a |
Pretax Income | -45.55M | -37.92M | -21.75M | -19.56M | -18.21M | -13.88M |
Net Income | -45.55M | -37.92M | -21.75M | -19.56M | -18.21M | -13.88M |
Selling & General & Admin | 27.8M | 23.43M | 6.99M | 6.38M | 6.65M | 6.51M |
Research & Development | 23.39M | 18.33M | 15.61M | 12.77M | 11.27M | 7.02M |
Other Expenses | -481K | -396K | -108K | n/a | n/a | n/a |
Operating Expenses | 50.71M | 41.37M | 22.49M | 19.16M | 17.92M | 13.53M |
Interest Expense | n/a | -3.29M | n/a | 33K | 32K | 6K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 51.19M | 41.77M | 22.49M | 19.16M | 17.93M | 13.66M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 46.56M | 36.21M | 10.26M | 1.39M | 1.92M | 1.01M |
Shares Outstanding (Diluted) | 46.56M | 36.21M | 10.28M | 1.39M | 1.92M | 1.01M |
EPS (Basic) | -0.98 | -1.05 | -2.68 | -14.12 | -19.31 | -27.27 |
EPS (Diluted) | -0.98 | -1.05 | -2.68 | -14.12 | -19.31 | -27.27 |
EBITDA | -51.19M | -41.37M | -22.15M | -18.7M | -17.78M | -13.45M |
EBIT | -51.19M | -41.77M | -22.49M | -19.08M | -18.18M | -13.88M |
Depreciation & Amortization | 481K | 396K | 343K | 381K | 392K | 424K |
Add to Watchlist
Select watchlists to add or remove BNTC